Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03902314 · ClinicalTrials.gov registry record · Phase 4
Lidocaine Infusion for Pain Relief in Children Scheduled for Tonsillectomy and Adenoidectomy
A Phase 4 study of Tonsillar Hypertrophy and Children, Only, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT03902314: Completed Phase 4 study of Tonsillar Hypertrophy and Children, Only, sponsored by Rhode Island Hospital.
NCT03902314 is a Phase 4 study of Tonsillar Hypertrophy and Children, Only that has completed, run by Rhode Island Hospital. The registered enrollment target is 70 participants, below the 184-participant average among 4 other Tonsillar Hypertrophy trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03902314, a Phase 4 study of Tonsillar Hypertrophy and Children, Only, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Lidocaine is widely available and is a very commonly used local anesthetic. When administered intravenously, lidocaine infusions have anti-inflammatory effects and have significantly decreased the reliance on opioid use for adequate pain management in adult abdominal and spine surgeries. A major advantage of lidocaine infusion is that it is not associated with a significant side effect profile.The role of lidocaine in pediatric acute perioperative pain remains limited.
Primary Outcome
FLACC scale includes 5 categories (Face, Legs, Activity, Cry, Consolability) of pain behaviors scored from 0-2 to provide a total pain score ranging from 0 to 10 with higher numbers indicating greater or worse pain.
Conditions Studied
Interventions
- DRUG Saline Solution
- DRUG Lidocaine Iv
Study Locations (1)
Rhode Island
- Hasbro Children's Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2019-05-07 |
| Est. Completion | 2021-12-06 |
| Phase | Phase 4 |
What the finished NCT03902314 record still lists
NCT03902314 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 184-participant average among 4 other Tonsillar Hypertrophy trials with a reported enrollment target (62% lower).
The record links to 3 conditions, with Tonsillar Hypertrophy appearing as the primary indexed condition, and to 2 interventions - of which Saline Solution is the first listed.
NCT03902314 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT03902314 about?
NCT03902314 is a clinical study titled "Lidocaine Infusion for Pain Relief in Children Scheduled for Tonsillectomy and Adenoidectomy". Lidocaine is widely available and is a very commonly used local anesthetic. When administered intravenously, lidocaine infusions have anti-inflammatory effects and have significantly decreased the reliance on opioid use for adequate pain management in adult abdominal and spine surgeries. A major adv...
What is the current status of trial NCT03902314?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2019-05-07. Estimated completion is 2021-12-06.
What conditions does trial NCT03902314 study?
This clinical trial studies the following conditions: Tonsillar Hypertrophy, Children, Only, Adenoid Hypertrophy.
What interventions are being tested in trial NCT03902314?
The interventions under investigation include: Saline Solution (DRUG), Lidocaine Iv (DRUG).
Who is sponsoring clinical trial NCT03902314?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03902314 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tonsillar Hypertrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia
RECRUITING · Phase 4
-
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
RECRUITING · NA
-
Metabolomic Profiling of Racial Disparity
ACTIVE NOT RECRUITING
-
Management of Post-Tonsillectomy Pain in Pediatric Patients
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI